Biomarker-driven clinical trials for anti-cancer drug development

被引:0
|
作者
Kim, Dong-Wan [1 ]
机构
[1] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IS12-3
引用
收藏
页码:1703 / 1703
页数:1
相关论文
共 50 条
  • [21] Indian anti-cancer drug trials halted
    Sharma, DC
    LANCET, 1999, 353 (9154): : 735 - 735
  • [22] The role of the pathologist in the design and conducting of biomarker-driven clinical trials in cancer: position paper of the European Society of Pathology
    Matias-Guiu, Xavier
    Raspollini, Maria Rosaria
    Kulka, Janina
    Ryska, Ales
    Dieri, Raed Al
    Schirmacher, Peter
    European Society of Pathology ESP
    VIRCHOWS ARCHIV, 2024, : 207 - 214
  • [23] Efficiency of Biomarker-Driven Clinical Trial Designs
    Freidlin, Boris
    Korn, Edward L.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (12)
  • [24] BIOMARKER-DRIVEN PROGRAMS FOR LUNG CANCER SCREENING
    Massion, Pierre
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S6 - S6
  • [25] Clinical Trials and Approval of Anti-cancer Agents
    Iwasaki, Masaru
    Hinotsu, Shiro
    Katsura, Jun
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 : i65 - i69
  • [26] Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
    Chenyue Zhang
    Haiyong Wang
    Signal Transduction and Targeted Therapy, 6
  • [27] Efficiency of Biomarker-Driven Clinical Trial Designs Reply
    Lee, Choong-kun
    Park, Sejung
    Nam, Chung Mo
    Chung, Hyun Cheol
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (12)
  • [28] A State-of-the-Art Roadmap for Biomarker-Driven Drug Development in the Era of Personalized Therapies
    Serelli-Lee, Victoria
    Ito, Kazumi
    Koibuchi, Akira
    Tanigawa, Takahiko
    Ueno, Takayo
    Matsushima, Nobuko
    Imai, Yasuhiko
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [29] Therapeutic utility of Lung-MAP: ushering into an era of genomic and biomarker-driven clinical trials
    Zhang, Chenyue
    Wang, Haiyong
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [30] Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trials
    LoRusso, Patricia M.
    Freidlin, Boris
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (02): : 122 - 124